No Data
No Data
There's A Lot To Like About Weihai Baihe Biology Technological's (SHSE:603102) Upcoming CN¥0.75 Dividend
Weihai Baihe Biology Technological Co., Ltd. (SHSE:603102) stock is about to trade ex-dividend in three days. The ex-dividend date is one business day before the record date, which is the cut-off dat
Lily Shares (603102.SH) will pay 7.5 yuan for every 10 shares in 2023. The share registration date is May 31
Lily Co., Ltd. (603102.SH) announced that the company will implement the 2023 annual equity distribution to all shares...
Lily Co., Ltd. (603102.SH): Net profit in 2023 increased by 22.65% year-on-year, and plans to pay 10 to 7.5 yuan
On April 11, Ge Longhui Co., Ltd. (603102.SH) announced its 2023 annual report. During the reporting period, it achieved operating income of 871 million yuan, an increase of 20.12%; net profit attributable to shareholders of listed companies was 169 million yuan, an increase of 22.65% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 163 million yuan, an increase of 22.34% year on year; and basic earnings per share. The company plans to distribute a cash dividend of 7.50 yuan (tax included) for every 10 shares to all shareholders.
Lily Shares (603102.SH): 1.59% of shares have been repurchased cumulatively
Gelonghui Co., Ltd. (603102.SH) announced on March 25, 2024, that as of March 23, 2024, the company had repurchased a total of 1.0204 million A-share common shares through the Shanghai Stock Exchange system, accounting for 1.59% of the company's current total share capital. The highest transaction price for the repurchase was RMB 39.50 yuan/share, the minimum transaction price was RMB 29.45 yuan/share, and the total amount of capital paid was RMB 388.432 million (excluding transaction fees such as stamp duty and transaction fees).
Lily Co., Ltd. (603102.SH): A total cost of 38.84 million yuan to buy back 1.59% of the shares
Gelonghui Co., Ltd. (603102.SH) announced on March 4, 2024, that as of February 29, 2024, the company had repurchased 1,020,400 shares of the company's shares through centralized bidding transactions, accounting for 1.59% of the company's current total share capital. The highest transaction price of the repurchase was RMB 39.50 per share, the minimum transaction price was RMB 29.45 per share, and the total amount of capital paid was RMB 38,843,216.76.
Following Recent Decline, Weihai Baihe Biology Technological Co., Ltd.'s (SHSE:603102) Top Shareholder CEO Xinli Liu Sees Holdings Value Drop by 17%
Key Insights Weihai Baihe Biology Technological's significant insider ownership suggests inherent interests in company's expansion A total of 5 investors have a majority stake in the company with 51
No Data